1.Tang J, Brynildsen M. Genome-wide mapping of fluoroquinolone-stabilized DNA gyrase cleavage sites displays drug specific effects that correlate with bacterial persistence. Nucleic Acids Res. 2023;51(3):1208–1228. PMCID: PMC9943676 Reference Link
1.Lemma A, Brynildsen M. Toxin Induction or Inhibition of Transcription or Translation Posttreatment Increases Persistence to Fluoroquinolones. mBio. 2021;12(4):e0198321. PMCID: PMC8406316 Reference Link
1.Murawski A, Brynildsen M. Ploidy is an important determinant of fluoroquinolone persister survival. Curr Biol. 2021;31(10):2039–2050.e7. PMCID: PMC8183807 Reference Link
1.Aedo S, Orman M, Brynildsen M. Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition. BMC Microbiol. 2019;19(1):140. PMCID: PMC6591824 Reference Link
1.Mok W, Park J, Rabinowitz J, Brynildsen M. RNA Futile Cycling in Model Persisters Derived from MazF Accumulation. mBio. 2015;6(6):e01588–15. PMCID: PMC4659464 Reference Link
